Styczyński, J., & Dreger, P. (2016). Impact of donor Epstein–Barr virus serostatus on the incidence of graft-versus-host disease in patients with acute leukemia after hematopoietic stem-cell transplantation: A study from the acute leukemia and infectious diseases working parties of the European Society for blood and marrow transplantation. Journal of clinical oncology, 34(19), . https://doi.org/10.1200/JCO.2015.64.2405
Chicago Style (17th ed.) CitationStyczyński, Jan, and Peter Dreger. "Impact of Donor Epstein–Barr Virus Serostatus on the Incidence of Graft-versus-host Disease in Patients with Acute Leukemia After Hematopoietic Stem-cell Transplantation: A Study from the Acute Leukemia and Infectious Diseases Working Parties of the European Society for Blood and Marrow Transplantation." Journal of Clinical Oncology 34, no. 19 (2016). https://doi.org/10.1200/JCO.2015.64.2405.
MLA (9th ed.) CitationStyczyński, Jan, and Peter Dreger. "Impact of Donor Epstein–Barr Virus Serostatus on the Incidence of Graft-versus-host Disease in Patients with Acute Leukemia After Hematopoietic Stem-cell Transplantation: A Study from the Acute Leukemia and Infectious Diseases Working Parties of the European Society for Blood and Marrow Transplantation." Journal of Clinical Oncology, vol. 34, no. 19, 2016, https://doi.org/10.1200/JCO.2015.64.2405.